Page 8 - Transcode Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TransCode Therapeutics Reports Further Restructuring to Reduce Expenses and Increased Focus on Planned Phase 1 Clinical Trial, Retirement of CEO

TransCode Therapeutics Reports Further Restructuring to Reduce Expenses and Increased Focus on Planned Phase 1 Clinical Trial, Retirement of CEO
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesZdravka medarovaMichael dudleyTom fitzgeraldPhilippe calaisVelico medical incTranscode therapeutics incExchange commissionCode therapeutics reports further restructuringReduce expensesIncreased focusPlanned phaseCode therapeuticsChief executive officerChief financial officerChief executive

TransCode Therapeutics Reports Further Restructuring to Reduce Expenses and Increased Focus on Planned Phase 1 Clinical Trial, Retirement of CEO

BOSTON, Jan. 12, 2024 TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported further steps in its.

United statesTom fitzgeraldMichael dudleyPhilippe calaisZdravka medarovaGlobenewswire incTranscode therapeutics incVelico medical incExchange commissionCode therapeuticsChief executive officerChief financial officerChief executiveChief technology officerChief scientificHoffmann la roche

TransCode Therapeutics (RNAZ) Publishes Open Letter to Shareholders, Proposed Reverse Split

TransCode Therapeutics (RNAZ) Publishes Open Letter to Shareholders, Proposed Reverse Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Philippe calaisR michael dudleyTranscode therapeutics incPartnership developmentsTherapeutic development programSaratoga proxy consultingTranscode therapeuticsExecutive officer

TransCode Therapeutics Publishes Open Letter Outlining

An Open Letter to Shareholders of TransCode Therapeutics, Inc..

United statesR michael dudleyTom fitzgeraldPhilippe calaisExchange commissionPartnership developmentsTherapeutic development programTranscode therapeutics incSaratoga proxy consultingCode therapeuticsExecutive officerPrivate securities litigation reform actAnnual reportNasdaq rnazTranscode therapeutics

TransCode Therapeutics Publishes Open Letter Outlining Company s Progress and Objectives

TransCode Therapeutics Publishes Open Letter Outlining Company s Progress and Objectives
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTom fitzgeraldPhilippe calaisR michael dudleyPartnership developmentsTherapeutic development programTranscode therapeutics incExchange commissionSaratoga proxy consultingDifficult financial marketsTranscode raised new capitalFirst in class compound designedTreat metastaticCode therapeuticsExecutive officerPrivate securities litigation reform act